ATTENTION NEW JERSEY: Tell your Legislators to Support Natural Immunity for COVID-19
Our Stand: At-A-Glance
- Senators Joe Pennacchio & Michael Testa introduced legislation 4136_I1.PDF (state.nj.us) that would allow a person’s naturally developed immunity resulting from a prior COVID-19 infection to satisfy vaccination requirements.
- Bill S4136 would allow NJ entities to accept a person’s verbal confirmation that they have natural immunity due to a prior COVID-19 infection to satisfy any vaccination or testing requirement that may be imposed as a condition of employment or to receive services, participate in activities, attend school or college, or gain admission to a place or venue.
- “It is the intent of S4136 to reduce discrimination based on vaccination status and to ensure that all individuals, including those who have recovered from a SARS-CoV-2 infection and developed a natural immunity, are entitled to the exercise of any privilege or right granted under State or federal law, including the ability to obtain and maintain employment and to access places of public accommodation.”
- Public health policies have been based on the premise that natural immunity does not play an important role in protecting individuals. OSHA’s recent administrative rule requires that those who have had the COVID-19 virus still need to vaccinate or test, and wear a mask due to concern over accuracy of immunity testing. However, OSHA shows no concern over accuracy of the use of PCR tests for case discernment. OSHA mandate: Vaccine rule for larger employers, federal contractors and certain health care workers to take effect January 4
- In September 2021, Siri/Glimstad law firm filed a FOIA request, asking for “documents reflecting any documented case of an individual who (1) never received a Covid-19 vaccine; (2) was infected with Covid-19 once, recovered, and then later became infected again; and (3) transmitted SARS CoV-2 to another person when reinfected.” The CDC responded: ‘A search of our records failed to reveal any documents pertaining to your request. The CDC Emergency Operation Center (EOC) conveyed that this information is not collected.” The CDC replied admitting that they have no record of anyone who has recovered from SARS-CoV-2 infection spreading the virus post-recovery.
- Long-term immunity to the SARS-CoV-2 virus is expected following COVID-19 infection given the large number of immunogenic epitopes present in the proteome of the virus. In April 2020, Dr. James Lyons-Weiler published an analysis (validated by Harvard University) in which he identified over 50 epitopes in the SARS-CoV-2 proteome Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity - PubMed (nih.gov)
- A longitudinal study in Cell Reports Medicine followed 254 patients with mostly mild to moderate symptoms of SARS-CoV-2 infection over a period for more than eight months (250 days). The study authors reported that the patients’ immune responses to the virus remained durable and strong. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells: Cell Reports Medicine.
- Click to send a pre-drafted, customizable email asking your local legislators to support this crucial bill now. This legislation will save more than a million New Jerseyans with natural immunity from unnecessary harm, discrimination, and compliance burden.